Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP147387.RAQuZJtJnrvYBVFlNhDuXxyisgij5hgKhkIUAsNs6CtnI130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147387.RAQuZJtJnrvYBVFlNhDuXxyisgij5hgKhkIUAsNs6CtnI130_provenance.
• NP147386.RA_x7EBVMCzogkhTnTmEBy4qNdYhJSsxfWYC5bola-1gY130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147386.RA_x7EBVMCzogkhTnTmEBy4qNdYhJSsxfWYC5bola-1gY130_provenance.
• NP147380.RAFPHZ_oJOmA4Pkzsg6v5p4Ty0PjDZzPGN88hChmLqvTY130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147380.RAFPHZ_oJOmA4Pkzsg6v5p4Ty0PjDZzPGN88hChmLqvTY130_provenance.
• assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP210514.RARNCdqyulL6nc-zAE808ks571YzCyOjIe45cREAkVaYc130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210514.RARNCdqyulL6nc-zAE808ks571YzCyOjIe45cREAkVaYc130_provenance.
• NP210521.RAR6YIyuDtWqdFt2wXNnX50p4jqdh0k7ikM8Ou0usIj8U130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210521.RAR6YIyuDtWqdFt2wXNnX50p4jqdh0k7ikM8Ou0usIj8U130_provenance.
• NP211491.RAVuf7EoOHBPNFx8HCXfuGkC0vmDkUCGu7ZgODFYtazWM130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211491.RAVuf7EoOHBPNFx8HCXfuGkC0vmDkUCGu7ZgODFYtazWM130_provenance.
• NP283142.RAmQGyTrMqTqotiiwqwlv9pjOjPeCflOF87DYtvNZSGfE130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283142.RAmQGyTrMqTqotiiwqwlv9pjOjPeCflOF87DYtvNZSGfE130_provenance.
• NP499905.RAC_jfMvz1xZymnUXbK65tgN5GbLG0R1LGiTKi999kU2Q130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499905.RAC_jfMvz1xZymnUXbK65tgN5GbLG0R1LGiTKi999kU2Q130_provenance.
• NP210520.RAD7lTqCYxBTSOHgNMgLOH89bhRISG9LGzGNzKuJHk_zk130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP210520.RAD7lTqCYxBTSOHgNMgLOH89bhRISG9LGzGNzKuJHk_zk130_provenance.
• NP499906.RAJPh-LnGafAfAKSYWgZIpbzvGsDKkzOf80q2QPtZey4I130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP499906.RAJPh-LnGafAfAKSYWgZIpbzvGsDKkzOf80q2QPtZey4I130_provenance.
• NP211490.RA7wRKZnz8jC8kHomIHc7cvBmEBXqm9zGE6JZwePmE5Ww130_assertion description "[In gain-of-function CaSR mutations, the genetic abnormalities increase CaSR activity leading to the development of such clinical manifestations as hypercalciuric hypocalcemia and hypoparathyroidism.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211490.RA7wRKZnz8jC8kHomIHc7cvBmEBXqm9zGE6JZwePmE5Ww130_provenance.